SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ATIS is on the move!
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
2205 22 0 ATIS
Emcee:  Rick Costantino Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
655 Another reason for the lower-than-expected move is that Reuter did not report tJeffers Hughes-3/19/1997
654 Rajendra, There were some questions as to the possibility of a higher risk of Marshall Teitelbaum-3/19/1997
653 Marshall (and all others who contribute to a highly sensisble thread !) Thank Rajendra KRISHNAN-3/19/1997
652 Ed, Try contacting ATIS to find out. Otherwise, you could try contacting someMarshall Teitelbaum-3/19/1997
651 Don, A big move today wasn't expected actually. However, some upward moveMarshall Teitelbaum-3/19/1997
650 We need some information regarding preliminary orders for Dermagraft. Is there Ed Diaz-3/19/1997
649 Why did the stock not climb today, with the fda approval???? was looking for anDonald Watson, Jr.-3/19/1997
648 Jeffers, Just to clarify, the larger than predicted market spoken of by WebberMarshall Teitelbaum-3/18/1997
647 Marla and all on the thread, First, thanks for the post Marla. I spoke with BMarshall Teitelbaum-3/18/1997
646 Today I read a news alert from PR Newswire that noted in part "the U.S. Folegaled23-3/18/1997
645 Steve and all, On Zacks there was an issued company report by SG Warburg &Marshall Teitelbaum-3/14/1997
644 Marshall, I really can not understand why ATIS did not let DJ Reuter report thJeffers Hughes-3/13/1997
643 Marshall; I appreciated getting the information on ATIS management. Sounds likeSteve Lokness-3/13/1997
642 Jeffers, FWIW, it appears that ATIS didn't want to hype this info. It is Marshall Teitelbaum-3/12/1997
641 Steve, Your thoughts about management are right on target. This is definitelyMarshall Teitelbaum-3/12/1997
640 Lisa, Thanks for your well-thought out response. I was primarily interested iMarshall Teitelbaum-3/12/1997
639 Marshall; I appreciate your intelligent comments regarding ATIS and biotechs inSteve Lokness-3/12/1997
638 Marshall: I would be happy to respond to your question "regarding time frlwd-3/12/1997
637 Steve, You bring up some good points. It is correct that the pe ratio is geneMarshall Teitelbaum-3/11/1997
636 Jeffers, It couldn't hurt to check in and see what's up. It may be thMarshall Teitelbaum-3/11/1997
635 To all: ATIS has published a series of articles on D-TC in the journal of BJeffers Hughes-3/11/1997
634 LWD and all, Have been under the weather a bit the last few days, so less typiMarshall Teitelbaum-3/10/1997
633 Finally got a chance to review the GENZL Carticel registry report in detail. lwd-3/10/1997
632 Rick and Marshall; Marshall, your last question to Rick was one I was going to Steve Lokness-3/8/1997
631 Rick, I think you hit it on the head. There is a mad dash by pharmaceutical aMarshall Teitelbaum-3/8/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News